Adenosine Triphosphate
Active ingredient
Sold as Hydrate 2 · Hydrate 1
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Adenosine Triphosphate is an ingredient used in medications [1]. Its specific drug class is not provided in the source data. This ingredient is approved for use to help maintain a healthy level of hydration in the body [1].
In the market, medications containing Adenosine Triphosphate are available under various brand names, including Hydrate 2 and Hydrate 1 [1].
There was 1 adverse event report associated with this ingredient within the last 12 months [2]. The most frequently reported adverse events include arthralgia, asthenia, back pain, musculoskeletal disorder, and pain in the extremity [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | December 16, 2025 |
USUnited States· FDA
2 products
Uses
**
How to take
Sources & citations
- [1]FDA DailyMed · 1122605f-715e-4f… · revised December 16, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.